Microsoft Word[removed]ADCOM Addendum Title.doc

First Page		Document Content
Aging-associated diseases Medical emergencies Interventional cardiology Bristol-Myers Squibb Clopidogrel Prodrugs Coronary stent Percutaneous coronary intervention Myocardial infarction Medicine Cardiology Health		Microsoft Word[removed]ADCOM Addendum Title.doc Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 188,78 KB Share Document on Facebook

	A UNSPSC® Success Story University Health Care System Augusta, Georgia “My first day on the job, my boss told me to just pay attention to coronary stents and spinal implants. I DocID: 1rt6x - View Document
	Microsoft Word - PMDA-S-薬剤溶出型冠動脈ステント-070715_EE.docx DocID: 1remo - View Document
	Opportunity for Human Research Subjects Cardiovascular Inflammation Reduction Trial (CIRT). A randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of ca DocID: 1r6ms - View Document
	Advanced Cardiovascular Stent Incorporated with a Nitric Oxide Delivery System Investigators: Hai-Lung Tsai (, ), Adam Hamdorf, Cheng-Hsiang Lin, Patrick Margavio, Chi H Lee (UMKC), Richard Hopki DocID: 1qd5n - View Document
	ABSORB STENT APPROVED FOR THE U.S. For people with coronary artery disease, Absorb offers something unique. While most stents are made of metal, Absorb is made of a naturally dissolvable material. It dissolves completely DocID: 1oym7 - View Document